Top Markets
Coin of the day
BioMark Diagnostics Inc. BioMark Diagnostics Inc.

BioMark Diagnostics Inc.

BUX
Rang in aandelen #26586
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aandeelprijs
$0.36696844
Marktkapitalisatie
$38.56M
Verandering (1 dag)
-13.79%
Verandering (1 jaar)
45.45%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)

Categorie

Koersgeschiedenis voor BioMark Diagnostics Inc. (BUX)
Hoogste slotkoers: $0.41 op 2026-08-01

Laagste slotkoers: $0.55 op 2014-11-01
Koersgeschiedenis van BioMark Diagnostics Inc. van 2014 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 4.99%
2025 135.03%
2024 -25.11%
2023 32.68%
2022 -33.02%
2021 111.86%
2020 -46.86%
2019 440.36%
2018 -51.95%
2017 -3.44%
2016 -6.17%
2015 -82.61%
2014 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$625.27 26.37%
US
$216.72 2.52%
US
$24.33 90.18%
CN
$324.26 101.86%
US
$156.27 31.20%
US